Glancy Prongay Wolke & Rotter LLP reminds Insulet Corporation investors that the deadline to file a lead plaintiff motion in a securities fraud class action is August 31, 2026. The lawsuit covers investors who purchased or acquired Insulet securities between February 21, 2025 and May 26, 2026. The complaint alleges that the company made false and misleading statements and failed to disclose defects in its manufacturing controls, which created a risk of product safety violations. Two voluntary medical device corrections for Omnipod pods were announced in March and May 2026, causing stock price drops of 6.9% and 5.1% respectively.
Insulet CorporationSecurities fraud class action lawsuit alleging false statements and undisclosed manufacturing defects, with product corrections causing stock drops.